PXD015337 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | Therapeutic miR-132 inhibition reverses heart failure |
Description | Despite some success of pharmacotherapies targeting primarily neurohormonal dysregulation, heart failure is a growing global pandemic with increasing burden. Treatments that improve the disease by reversing heart failure at the cardiomyocyte level are lacking. MicroRNAs (miRNA) are transcriptional regulators of gene expression, acting through complex biological networks, and playing thereby essential roles in disease progression. Adverse structural remodelling of the left ventricle due to myocardial infarction (MI) is a common pathological feature leading to heart failure. We previously demonstrated increased cardiomyocyte expression of the miR-212/132 family during pathological cardiac conditions. Transgenic mice overexpressing the miR-212/132 cluster (miR-212/132-TG) develop pathological cardiac remodelling and die prematurely from progressive HF. Using both knockout and antisense strategies, we have shown miR-132 to be both necessary and sufficient to drive the pathological growth of cardiomyocytes in a murine model of left ventricular pressure overload. Based on the findings, we proposed that miR-132 may serve as a therapeutic target in heart failure therapy. Here we provide novel mechanistic insight and translational evidence for the therapeutic efficacy in small and large animal models (n=135) of heart failure. We demonstrate strong PK/PD relationship, dose-dependent efficacy and high clinical potential of a novel optimized synthetic locked nucleic acid phosphorothioate backbone antisense oligonucleotide inhibitor of miR-132 (antimiR-132) as a next-generation heart failure therapeutic. |
HostingRepository | PRIDE |
AnnounceDate | 2020-01-09 |
AnnouncementXML | Submission_2020-01-09_10:51:42.xml |
DigitalObjectIdentifier | https://dx.doi.org/10.6019/PXD015337 |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Supported dataset by repository |
PrimarySubmitter | Xiaoke Yin |
SpeciesList | scientific name: Rattus norvegicus (Rat); NCBI TaxID: 10116; |
ModificationList | Oxidation; Carbamidomethyl |
Instrument | Orbitrap Fusion Lumos |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2019-09-06 01:00:58 | ID requested | |
⏵ 1 | 2020-01-09 10:51:43 | announced | |
Publication List
Dataset with its publication pending |
Keyword List
submitter keyword: Calcium Cycling/Excitation-Contraction Coupling, Contractile Function, Myocardial Biology, Translational Studies, Myocardial Infarction |
Contact List
Manuel Mayr |
contact affiliation | Cardiovascular Division, King's College London, London, UK |
contact email | manuel.mayr@kcl.ac.uk |
lab head | |
Xiaoke Yin |
contact affiliation | Cardiovascular Division, King's College London |
contact email | xiaoke.yin@kcl.ac.uk |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD015337 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD015337
- Label: PRIDE project
- Name: Therapeutic miR-132 inhibition reverses heart failure